9. RESULTS OF COVID-19 PREVENTION AND CONTROL AMONG HEALTHCARE PERSONNEL AND RELEVANT FACTORS AT NGUYEN TRI PHUONG HOSPITAL
Main Article Content
Abstract
Objective: A study conducted from May 2022 to December 2022 aimed to describe the management outcomes and analyze factors related to the management of COVID-19 prevention and control for healthcare workers at Nguyen Tri Phuong Hospital, Ho Chi Minh City.
Method: A cross-sectional study with a combined analysis of quantitative and qualitative data.
Results: The assessment of COVID-19 prevention and control activities at Nguyen Tri Phuong Hospital showed an average score above 80% for all three years. In 2020, the score was 82.7%, in 2021 it was 96.7%, and in 2022 it reached 98.7% according to the COVID-19 Safety Criteria. The COVID-19 infection rate among healthcare workers after receiving three doses of the COVID-19 vaccine was 45.4%. Doctors and nurses had a higher infection rate compared to other staff groups (p=0.019), clinical and paraclinical departments had a higher infection rate compared to functional departments (p=0.035), and frontline workers had a higher infection rate than those working in indirect and support roles (p=0.029). Several factors influencing the management and prevention of COVID-19 were identified through qualitative surveys, including job position, specialization, adherence to disease prevention regulations, complex disease progression, infrastructure, specialized operational guidelines, policies, and human resources.
Conclusion: The assessment of COVID-19 prevention and control activities at Nguyen Tri Phuong Hospital consistently showed an average score above 80% for all three years. Several factors influencing the management and prevention of COVID-19 were identified, including job position, specialization, adherence to disease prevention regulations, complex disease progression, infrastructure, specialized operational guidelines, policies, and human resources.
Article Details
Keywords
Management, COVID-19, healthcare workers.
References
Delta VOC in Scotland: demographics,
risk of hospital admission, and vaccine
effectiveness. Lancet (London, England),
397(10293), 2021, pp. 2461–2462.
[2] Khoury J, Najjar-Debbiny R, Hanna A et al.,
COVID-19 vaccine - Long term immune decline
and breakthrough infections. Vaccine, 39(48),
2021, pp. 6984–6989.
[3] Rovida F, Cassaniti I, Paolucci S et al., SARSCoV-2
vaccine breakthrough infections with
the alpha variant are asymptomatic or mildly
symptomatic among health care workers. Nature
communications, 12(1), 2021, pp. 6032.
[4] Chau NV, Ngoc NM, Nguyet LA et al., An
observational study of breakthrough SARSCoV-2
Delta variant infections among
vaccinated healthcare workers in Vietnam.
EClinicalMedicine, 41, 2021, pp. 101143.
[5] Intawong K, Chariyalertsak S, Chalom K et al.,
Effectiveness of heterologous third and fourth
dose COVID-19 vaccine schedules for SARSCoV-2
infection during delta and omicron
predominance in Thailand: a test-negative,
case-control study. The Lancet regional health.
Southeast Asia, 10, 2023, pp. 1-9.
[6] Pullen MF, Skipper CP, Hullsiek KH et al.,
Symptoms of COVID-19 Outpatients in the
United States. Open forum infectious diseases,
7(7), pp. ofaa271.
[7] Brophy, J. T., Keith, M. M., Hurley, M., &
McArthur, J. E. (2021). Sacrificed: Ontario
Healthcare Workers in the Time of COVID-19.
New solutions : a journal of environmental and
occupational health policy: NS, 30(4), 2020, pp.
267-281.
[8] Gralinski EL, Menachery DV, Return of the
Coronavirus: 2019-nCoV. Viruses, 12(2), 2020,
pp. 1-8.
[9] Levin EG, Lustig Y, Cohen C et al., Waning
Immune Humoral Response to BNT162b2
COVID-19 Vaccine over 6 Months. The New
England journal of medicine, 385(24), 2021,
pp. 1-11.